It is widely known that ERBB2 can be activated by overexpression, amplification, or alteration in multiple cancers, for instance, breast cancer, bladder cancer, and lung cancer, which has also been identified in patients with BTC. The gene discussed is ERBB2; the disease is urinary bladder carcinoma.